169
Views
17
CrossRef citations to date
0
Altmetric
Clinical reviews

Review: timing of office visits can be a powerful tool to improve adherence in the treatment of dermatologic conditions

, &
Pages 82-88 | Received 27 Jan 2011, Accepted 17 Apr 2011, Published online: 24 Feb 2013

References

  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487–497.
  • Rand CS, Wise RA, Nides M, Simmons MS, Bleecker ER, Kusek JW, Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992;146:1559–1564.
  • Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 2004;51:212–216.
  • Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol 2007;57:81–83.
  • Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D, Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol 2007;56:211–216.
  • Wilson R, Camacho F, Clark AR, Young T, Inabinet R, Yentzer BA, Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis. J Am Acad Dermatol 2009;60:166–168.
  • Aliotta SL, Vlasnik JJ, Delor B. Enhancing adherence to long-term medical therapy: a new approach to assessing and treating patients. Adv Ther 2004;21:214–231.
  • Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol 2004;4:191–195.
  • Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001;26:331–342.
  • Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990;150:1377–1378.
  • Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990;150:1509–1510.
  • Krejci-Manwaring J, McCarty MA, Camacho F, Carroll CL, Johnson K, Manuel J, Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol 2006;54:S235–S236.
  • Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol 1986;101:515–523.
  • Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, de la Figuera-Von Wichmann, Casado-Martinez JJ, Martin-de Pablos JL, Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. J Hypertens 2006;24:169–175.
  • Podsadecki TJ, Vrijens BC, Tousset EP, Rode RA, Hanna GJ. “White coat compliance” limits the reliability of therapeutic drug monitoring in HIV-1-infected patients. HIV Clin Trials 2008;9:238–246.
  • van Onzenoort HA, Verberk WJ, Kroon AA, Kessels AG, Nelemans PJ, van der Kuy PH, Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-to-moderate hypertension. J Hypertens 2010;28:622–627.
  • Simmons MS, Nides MA, Rand CS, Wise RA, Tashkin DP. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest 1996;109:963–968.
  • Rudd P, Ahmed S, Zachary V, Barton C, Bonduelle D. Improved compliance measures: applications in an ambulatory hypertensive drug trial. Clin Pharmacol Ther 1990;48:676–685.
  • Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens 1996;9:719–725.
  • Guerrero D, Rudd P, Bryant-Kosling C, Middleton B, Middleton BF. Corrected to Middleton. Antihypertensive medication-taking. Investigation of a simple regimen. Am J Hypertens 1993;6:586–592.
  • Thornburg CD, Rogers ZR, Jeng MR, Rana SR, Iyer RV, Faughnan L, Adherence to study medication and visits: data from the BABY HUG trial. Pediatr Blood Cancer 2010;54:260–264.
  • Wannamaker BB, Morton WA Jr, Gross AJ, Saunders S. Improvement in antiepileptic drug levels following reduction of intervals between clinic visits. Epilepsia 1980;21:155–162.
  • Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol 2007;144:533–540.
  • Baldwin HE. Tricks for improving compliance with acne therapy. Dermatol Ther 2006;19:224–236.
  • Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol 2006;55:607–613.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.